LGND

Ligand Pharma

• TipRanks·1d ago

  Ligand price target raised to $406 from $388 at BofA

• TipRanks·1d ago

  Ligand Pharma (LGND) Receives a Buy from Bank of America Securities

• Benzinga·10/13 14:15

  Here's How Much $1000 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today

• Seeking Alpha·10/01 16:30

  StoneX updates its best ideas list

• Seeking Alpha·09/25 18:19

  Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation

• TipRanks·09/25 13:45

  Twilio downgraded, Synopsys upgraded: Wall Street’s top analyst calls

• Dow Jones·09/25 12:39

  Ligand Pharmaceuticals Price Target Announced at $345.00/Share by Barclays

• Dow Jones·09/25 12:39

  Ligand Pharmaceuticals Initiated at Overweight by Barclays

• Benzinga·09/25 12:30

  Barclays Initiates Coverage On Ligand Pharmaceuticals with Overweight Rating, Announces Price Target of $345

• TipRanks·09/25 08:50

  Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Natera (NTRA) and Aveanna Healthcare Holdings (AVAH)

• TipRanks·09/25 08:45

  Ligand initiated with an Overweight at Barclays

• Seeking Alpha·09/24 17:17

  Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies

• Dow Jones·09/24 16:04

  Ligand Pharmaceuticals Price Target Maintained With a $358.00/Share by HC Wainwright & Co.

• Benzinga·09/24 15:54

  HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $358 Price Target

• TipRanks·09/24 15:10

  Wainwright sees upside in Ligand after new CAR-T investment in AvenCell